We're delighted to add a summary of a recent speaker event titled: Personalising type 2 asthma treatment with dupilumab — evidence and clinical experience.
The presentations were given by Professor Michael Wechsler, Professor of Medicine at NJH in Denver and Director of the National Jewish Health/Cohen Family Asthma Institute; and Professor David Langton, an intensive care, respiratory and sleep medicine specialist based in Melbourne.
Please login below to download this issue (PDF)